apalcillin has been researched along with Biliary-Tract-Diseases* in 3 studies
3 other study(ies) available for apalcillin and Biliary-Tract-Diseases
Article | Year |
---|---|
[Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)].
Piperacillin, a new injectable synthetic penicillin, was evaluated against biliary tract infections. 1. Two grams of piperacillin was intravenously administered to patients received cholecystectomy. The mean level in gallbladder bile of PIPC was 795.6 microgram/ml except for 3 cases in obstruction of the cystic duct. The mean gallbladder tissue level was 31.2 microgram/g. The gallbladder tissue level in the cases with obstruction of the cystic duct was high levels as 71.3 microgram/g and 79.5 microgram/g. 2. The excretion of PIPC into bile was compared with TIPC and APPC using crossover method. When administered 2 g of PIPC, the peak biliary levels were 950 microgram/ml to 2,120 microgram/ml at 2 hours and 20 minutes to 2 hours and 40 minutes after the administration, and biliary recoveries during 6 hours were 2.84% to 11.6%. The peak levels and biliary recoveries were lower after administration of TIPC 2 g. Mn and Zn were excreted enormously together with APPC into human bile. 3. The influence on clinical laboratory findings was negligible. Therefore, PIPC may be expected to show excellent effects of biliary tract infections except rare occurrence of drug eruption. Topics: Adult; Aged; Ampicillin; Bacterial Infections; Bile; Biliary Tract Diseases; Female; Gallbladder; Humans; Injections, Intravenous; Male; Middle Aged; Naphthyridines; Penicillins; Piperacillin; Ticarcillin; Trace Elements | 1981 |
[Clinical studies on PC-904 in biliary tract diseases (author's transl)].
The clinical effects of PC-904, a new semisynthetic penicillin, were studied in patients with biliary tract diseases, and the results were as follows: 1) PC-904 showed an average peak serum level of 40.7 +/- 11.6 microgram/ml 2 hours after an intravenous drip infusion of 1 g of the agent. The biliary level showed a peak value of 126.5 +/- 85.4 microgram/ml 2 hours to 3 hours after the infusion. 2) Isolated organisms from bile before the treatment were E. coli, Klebsiella, Proteus, Pseudomonas, Enterococcus and Bacteroides. MIC of PC-904 on 18 strains of isolated organisms was almost 6.25 microgram/ml or less. All isolated organisms except one strain of Klebsiella oxytoca disappeared after the treatment. 3) Six patients with cholelithiasis were medicated with PC-904 to prevent post-operative infections. The clinical effects were good in 4, poor in 1 and unknown in 1 case. 4) As to side effects no adverse reactions and allergic reactions were noted. Also no significant abnormalities of laboratory findings were observed. Topics: Ampicillin; Bacteria; Bile; Biliary Tract; Biliary Tract Diseases; Humans; Naphthyridines | 1979 |
[Clinical studies on apalcillin in biliary tract infections (author's transl)].
Clinical studies on apalcillin (APPC), a new broad spectrum semisynthetic penicillin developed in Japan, were carried out, and the following results were obtained. APPC was administered to three patients with serious biliary tract infections by intramuscular or intravenous injection at daily dosage of 2. Therapeutic responses were excellent in all cases, and no side effects and abnormalities of laboratory findings were observed. APPC was considered to be an excellent drug for the treatment of biliary tract infections. Topics: Adult; Ampicillin; Biliary Tract Diseases; Cholangitis; Cholecystitis; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Naphthyridines | 1979 |